What is the recommended pain management regimen for acute gout (gouty arthritis) flare?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a gout flare, I recommend a combination approach using anti-inflammatory medications, starting with colchicine 1.2mg immediately, followed by 0.6mg one hour later, then continuing with 0.6mg once or twice daily until the flare resolves, as supported by high-quality evidence from the American College of Physicians guideline 1.

Key Recommendations

  • Colchicine: Start with 1.2mg immediately, followed by 0.6mg one hour later, then continue with 0.6mg once or twice daily until the flare resolves 1.
  • NSAIDs: Use an NSAID like naproxen 500mg twice daily or indomethacin 50mg three times daily for 3-5 days as an alternative to colchicine 1.
  • Corticosteroids: For those who cannot take these medications, prednisone 30-40mg daily for 3-5 days with a gradual taper over 10-14 days is effective 1.

Additional Measures

  • Apply ice to the affected joint for 20 minutes several times daily.
  • Elevate the joint and rest.
  • Drink plenty of water.
  • Avoid alcohol and purine-rich foods (red meat, seafood, organ meats) during the flare.

Long-term Management

  • Discuss long-term urate-lowering therapy with your healthcare provider to prevent future attacks, considering the patient's individual preferences, benefits, and harms of treatment 1.

From the FDA Drug Label

The efficacy of a low-dosage regimen of oral colchicine (total dose 1. 8 mg over one hour) for treatment of gout flares was assessed in a multicenter, randomized, double-blind, placebo-controlled, parallel group, one week, dose-comparison study. Patients meeting American College of Rheumatology criteria for gout were randomly assigned to three groups: high-dose colchicine (1.2 mg, then 0.6 mg hourly × six hours [4.8 mg total]); low-dose colchicine (1.2 mg, then 0. 6 mg in one hour [1. 8 mg total] followed by five placebo doses hourly); or placebo (two capsules, then one capsule hourly × six hours). Rates of response were similar for the recommended low-dose treatment group (38%) and the nonrecommended high-dose group (33%) but were higher as compared to the placebo group (16%)

The recommended pain management regimen for acute gout (gouty arthritis) flare is low-dose colchicine with a total dose of 1.8 mg over one hour.

  • The dose is 1.2 mg, then 0.6 mg in one hour.
  • This regimen has been shown to be effective in reducing pain in patients with acute gout flare, with a response rate of 38% 2.
  • Indomethacin is also an option for the treatment of acute gouty arthritis, as it has been found to be effective in relieving the pain, reducing the fever, swelling, redness, and tenderness of acute gouty arthritis 3.

From the Research

Recommended Pain Management Regimen for Acute Gout

The recommended pain management regimen for acute gout (gouty arthritis) flare includes:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) 4, 5, 6, 7
  • Colchicine 4, 5, 6, 7
  • Corticosteroids (oral or intramuscular) 4, 5, 6, 7
  • Interleukin-1 (IL-1) inhibitors, such as canakinumab and rilonacept, for flare refractory to standard therapies 4, 5, 8

Prophylaxis for Acute Gout Flares

Prophylaxis for acute gout flares is recommended when initiating urate-lowering therapy, with options including:

  • Low-dose colchicine (0.5 mg once or twice a day) 5
  • Low-dose NSAIDs, such as naproxen 250 mg orally twice a day 5
  • Low-dose corticosteroids, such as prednisone or prednisolone, if contraindicated or not tolerated 5
  • IL-1 inhibitors, such as canakinumab and rilonacept, for patients with intolerance or contraindication to colchicine, NSAIDs, or corticosteroids 5, 8

Urate-Lowering Therapy

Urate-lowering therapy aims to prevent gout flares, with options including:

  • Allopurinol and febuxostat as initial treatments 4, 6, 7
  • Uricosuric agents, such as probenecid, sulfinpyrazone, and benzbromarone, as adjuncts 4, 6
  • Emerging therapies in development 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An update on the pharmacotherapy of gout.

Expert opinion on pharmacotherapy, 2025

Research

Gout--what are the treatment options?

Expert opinion on pharmacotherapy, 2009

Research

Interleukin-1 inhibitors for acute gout.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.